Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.
Gynecol Oncol. 2021 Oct;163(1):50-56. doi: 10.1016/j.ygyno.2021.07.026. Epub 2021 Jul 21.
Gynecol Oncol. 2021.
PMID: 34301411
Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay.
Chase DM, Neighbors J, Perhanidis J, Monk BJ.
Chase DM, et al. Among authors: perhanidis j.
Gynecol Oncol. 2021 Jun;161(3):832-837. doi: 10.1016/j.ygyno.2021.03.021. Epub 2021 Apr 1.
Gynecol Oncol. 2021.
PMID: 33814195
Item in Clipboard
Association of Multiple High-Risk Factors on Observed Outcomes in Real-World Patients With Advanced Ovarian Cancer Treated With First-Line Therapy.
Chase D, Perhanidis J, Gupta D, Kalilani L, Golembesky A, González-Martín A.
Chase D, et al. Among authors: perhanidis j.
JCO Clin Cancer Inform. 2023 Jun;7:e2200189. doi: 10.1200/CCI.22.00189.
JCO Clin Cancer Inform. 2023.
PMID: 37294913
Free article.
Item in Clipboard
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance.
Chase D, Perhanidis J, Gupta D, Kalilani L, Golembesky A, González-Martín A.
Chase D, et al. Among authors: perhanidis j.
Oncol Ther. 2023 Jun;11(2):245-261. doi: 10.1007/s40487-023-00227-6. Epub 2023 Apr 4.
Oncol Ther. 2023.
PMID: 37016186
Free PMC article.
Item in Clipboard
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Rimel BJ, Chase DM, Perhanidis J, Ghazarian AA, Du EX, Wang T, Song J, Golembesky AK, Hurteau JA, Kalilani L, Salani R, Monk BJ.
Rimel BJ, et al. Among authors: perhanidis j.
Gynecol Oncol Rep. 2024 Feb 7;51:101332. doi: 10.1016/j.gore.2024.101332. eCollection 2024 Feb.
Gynecol Oncol Rep. 2024.
PMID: 38362364
Free PMC article.
Item in Clipboard
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
Meigs JB, Williams K, Sullivan LM, Hunt KJ, Haffner SM, Stern MP, González Villalpando C, Perhanidis JS, Nathan DM, D'Agostino RB Jr, D'Agostino RB Sr, Wilson PW.
Meigs JB, et al. Among authors: perhanidis js.
Diabetes Care. 2004 Jun;27(6):1417-26. doi: 10.2337/diacare.27.6.1417.
Diabetes Care. 2004.
PMID: 15161798
Item in Clipboard
E-selectin genotypes and risk of type 2 diabetes in women.
Meigs JB, Hu FB, Perhanidis JS, Hunter D, Rifai N, Manson JE.
Meigs JB, et al. Among authors: perhanidis js.
Obes Res. 2005 Mar;13(3):513-8. doi: 10.1038/oby.2005.54.
Obes Res. 2005.
PMID: 15833936
Free article.
Item in Clipboard
Cite
Cite